Intravenous Therapy (IV) Treatment

Indications for Use

When using stem cells for chronic disease and illness prevention it needs to be understood that the outcome is often not known, although clinicians have recommended IV treatment for the following treatments:

1. Systemic Inflammatory and Autoimmune Disorders

• Rheumatoid arthritis.
• Lupus (systemic lupus erythematosus).
• rohn’s disease and ulcerative colitis.

2. Neurological and Neurodegenerative Conditions

• Multiple sclerosis (MS).
• Alzheimer’s disease.
• Parkinson’s disease.
• Stroke recovery.

3. Chronic Inflammatory Diseases

• Fibromyalgia.
• Chronic fatigue syndrome.
• Post-COVID syndrome (long COVID).

4. Anti-Aging and General Wellness

• Cellular rejuvenation and recovery.
• Boosting immune function.
• Supporting metabolic health and systemic repair.

5. Cardiovascular and Pulmonary Conditions

• Heart failure and ischemic heart disease.
• Chronic obstructive pulmonary disease (COPD).

Procedure Overview

When using stem cells for chronic disease and illness prevention it needs to be understood that the outcome is often not known, although clinicians have recommended IV treatment for the following treatments:

1. Patient Evaluation

• Conduct a comprehensive clinical assessment of the patient, including a detailed medical history and a physical examination.
• It is recommended that a clinician use laboratory tests to evaluate markers of inflammation, autoimmune activity, or organ function as relevant to the patient’s condition.
• It is also recommended that the clinician perform eligibility screening by confirming that the patient has no contraindications such as active infections, coagulation disorders, or severe organ failure.

2. Administration

• Per the clinic’s procedures, establish a sterile environment and prepare the necessary IV equipment and materials (e.g., saline solution for dilution of biologics).
• Typical IV Stem Cell Therapy amount is 4 cc.
• Place an intravenous catheter in a suitable vein, ensuring proper technique to minimize discomfort and risks. Administer the biologic material through the IV line, typically diluted in saline to facilitate smooth infusion.
• The infusion is generally slow (20–60 minutes), depending on the volume and patient tolerance.
• Observe the patient for any immediate reactions, such as hypersensitivity, nausea, or changes in vital signs.

3. Post-Procedure Care

• Immediately following the procedure, monitor the patient for 15-20 minutes to ensure there are no adverse reactions.
• Provide instructions for follow-up care including avoiding strenuous activities for 24-48 hours, avoiding alcohol, and staying hydrated.
• Schedule a follow-up appointment per your internal procedures.
• Typical IV stem cell therapy protocol is 2-4 IV treatments, each treatment being every 2-3 months.

Sources

Shen, Z., Huang W., Liu J.; et al. Effects of Mesenchymal Stem Cell-Derived Exosomes on Autoimmune Diseases. Front. Immunol., 26 September 2021.Sec. Immunological Tolerance and Regulation Volume 12 – 2021. https://doi.org/10.3389/fimmu.2021.749192

Samavati, S.F., Yarani, R., Kiani, S. et al. Therapeutic potential of exosomes derived from mesenchymal stem cells for treatment of systemic lupus erythematosus. J Inflamm 21, 20 (2024). https://doi.org/10.1186/s12950-024-00381-2

Fayazi, N., Sheykhhasan, M., Soleimani Asl, S. et al. Stem Cell-Derived Exosomes: a New Strategy of Neurodegenerative Disease Treatment. Mol Neurobiol 58, 3494–3514 (2021). https://doi.org/10.1007/s12035-021-02324-x

Tao, H., Gao, B. Exosomes for neurodegenerative diseases: diagnosis and targeted therapy. J Neurol 271, 3050–3062 (2024). https://doi.org/10.1007/s00415-024-12329-w

Zhong, L., Wang, J., Wang, P. et al. Neural stem cell-derived exosomes and regeneration: cell-free therapeutic strategies for traumatic brain injury. Stem Cell Res Ther 14, 198 (2023). https://doi.org/10.1186/s13287-023-03409-1